www.npr.org
Open in
urlscan Pro
2600:1400:d:5a0::1155
Public Scan
Submitted URL: https://apple.news/ADEn8wIB5RoSUJ2t-uwWDTw?articleList=AioKfgtJzRriHNXm1Z43WHQ
Effective URL: https://www.npr.org/sections/goatsandsoda/2022/09/07/1121599445/so-you-havent-caught-covid-yet-does-that-mean-youre-...
Submission: On September 25 via api from CA — Scanned from CA
Effective URL: https://www.npr.org/sections/goatsandsoda/2022/09/07/1121599445/so-you-havent-caught-covid-yet-does-that-mean-youre-...
Submission: On September 25 via api from CA — Scanned from CA
Form analysis 1 forms found in the DOM
<form id="callout__form--newsletter" class="callout__form"><label for="callout__input">E-mail address</label><input type="hidden" name="newsletterId" value="goats-and-soda"><input class="callout__input" id="callout__input" type="email" name="email"
placeholder="What's your email?">
<div class="g-recaptcha" data-sitekey="6LfD6CYUAAAAAIBeUekwZ9KCjF4UyLFtu7NWNaEK" data-callback="onNewsletterSubmitRecaptcha" data-error-callback="onNewsletterErrorRecaptcha" data-size="invisible"></div><button class="callout__submit"
type="submit"><span class="callout__submit-text">subscribe</span></button>
</form>Text Content
Accessibility links
* Skip to main content
* Keyboard shortcuts for audio player
Play Live Radio
* Hourly News
* Listen Live
* Playlist
* Open Navigation Menu
*
*
* Sign In
* NPR Shop
* Donate
> Close Navigation Menu
* Home
* News Expand/collapse submenu for News
* National
* World
* Politics
* Business
* Health
* Science
* Climate
* Race
* Culture Expand/collapse submenu for Culture
* Books
* Movies
* Television
* Pop Culture
* Food
* Art & Design
* Performing Arts
* Life Kit
* Music Expand/collapse submenu for Music
* Tiny Desk
* #NowPlaying
* All Songs Considered
* Music Features
* Live Sessions
* Podcasts & Shows Expand/collapse submenu for Podcasts & Shows
Daily
* Morning Edition
* Weekend Edition Saturday
* Weekend Edition Sunday
* All Things Considered
* Fresh Air
* Up First
Featured
* Planet Money
* Rough Translation
* Life Kit
* NPR's Book of the Day
* More Podcasts & Shows
* Search
* Sign In
* NPR Shop
*
* Tiny Desk
* #NowPlaying
* All Songs Considered
* Music Features
* Live Sessions
* About NPR
* Diversity
* Organization
* Support
* Careers
* Connect
* Press
* Ethics
So you haven't yet caught COVID. Does that make you a superdodger? : Goats and
Soda A new study suggests that. yes, there are superdodgers. But explaining why
they've been able to avoid the virus is a bit complicated.
GOATS AND SODA
STORIES OF LIFE IN A CHANGING WORLD
* About Us
* Contact Us
* Infectious Disease
* Development
* Women & Girls
* Coronavirus FAQ
* Twitter
SO YOU HAVEN'T CAUGHT COVID YET. DOES THAT MEAN YOU'RE A SUPERDODGER?
* Facebook
* Twitter
* Flipboard
* Email
September 7, 20224:06 PM ET
Michaeleen Doucleff
Twitter
Enlarge this image
Do some people have built-in protection against a COVID infection? Laura Gao for
NPR hide caption
toggle caption
Laura Gao for NPR
Do some people have built-in protection against a COVID infection?
Laura Gao for NPR
Back in the early 1990s, Nathaniel Landau was a young virologist just starting
his career in HIV research. But he and his colleagues were already on the verge
of a landmark breakthrough. Several labs around the world were hot on his team's
tail.
"We were sleeping in the lab, just to keep the work going day and night because
there were many labs all racing against each other," Landau says. "Of course, we
wanted to be the first to do it. We were totally stressed out."
Other scientists had identified groups of people who appeared to be completely
resistant to HIV. "People who knew they had been exposed to HIV multiple times,
mainly through unprotected sex, yet they clearly were not infected," Landau
explains.
HEALTH
JOE BIDEN SAYS THE COVID-19 PANDEMIC IS OVER. THIS IS WHAT THE DATA TELLS US
And so the race was on to figure out why: "Are these people just lucky or did
they really have a mutation in their genes that was protecting them from
infection?'" he asks.
Now 25 years later, scientists all over the world are trying to answer the same
question but about a different virus: SARS-CoV-2.
By this point in the pandemic, most Americans have had at least one bout of
COVID. For children under age 18, more than 80% have been infected, the Centers
for Disease Control and Prevention estimates.
Sponsor Message
But just as with HIV, some people have been exposed multiple times but never had
symptoms and never tested positive.
"We've heard countless anecdotes about nurses and health-care workers, being
exposed without any protection and remaining negative over and over again," says
pediatrician Jean-Laurent Casanova, who studies the genetics of viral resistance
at Rockefeller University. "Or people share a household with someone who's been
coughing for a couple of weeks, and one person stays negative."
So why haven't these people caught COVID? .
SHOTS - HEALTH NEWS
SCIENTISTS DEBATE HOW LETHAL COVID IS. SOME SAY IT'S NOW LESS RISKY THAN FLU
After two years of hunting, a team at the University of California, San
Francisco has come pretty close to answering the question.
"These findings are like hot off the presses," says immunogeneticist Jill
Hollenbach, who led this research. "We haven't published them yet. It's all
stuff that's been happening this summer."
Hollenbach and her team have found a genetic mutation doesn't prevent the virus
from infecting cells — that's what Landau was searching for — but still does
something remarkable: It prevents a person from having COVID symptoms.
Turns out, stopping an infection altogether is an extremely tough nut for our
bodies to crack.
What does it take to be a true superdodger?
Over the course of human history, scientists have identified only two instances
of true virus superdodgers. That is, where a specific mutation in their genes
makes people completely resistant to a virus. So that it slides off their cells,
"like water sliding off a glass window," as Casanova puts it.
In 2003, a team in London showed how some people never get a stomach bug, called
norovirus, which causes vomiting and diarrhea. The researchers found that one
mutation in their genes prevents them from making a molecule the virus needs to
infect the cell.
(In 1995, researchers in France figured out why some people appeared to never be
infected with a species of malaria, known as Plasmodium vivax. However, over the
past decade, further studies have clarified that these superdodgers actually do
become infected with the parasite, they simply don't show symptoms.)
By far, the most famous virus superdodgers are people protected against HIV. The
ones Landau and his colleagues were studying back in the early 1990s.
In 1996, his team was getting really close to solving that puzzle. One morning
they found a huge clue. The night before, they had set up an experiment to test
which molecules HIV needed to infect a human cell. The experiment garnered
spectacular results.
It showed that HIV didn't enter cells the way scientists had believed. Instead
it needed a little bit of extra help. Specifically, HIV needs a specific
molecule, called CCR5, on the surface of the cell to "open the door" and let the
virus enter, Landau says. Without CCR5, the virus only sticks to the cell's
surface but can't enter. "It's kind of like the virus is knocking at the door,
but nobody's opening the door. The door is locked," he says.
"That was what we call a eureka moment," Landau says. "That was the moment where
we could say, 'We found something that had never been seen before.' "
GOATS AND SODA
4 WAYS THE WORLD MESSED UP ITS PANDEMIC RESPONSE — AND 3 FIXES TO DO BETTER NEXT
TIME
Landau and his colleagues rushed to the computer and wrote up the findings as
quickly as possible. Then he literally ran to the FedEx store to submit the
paper to the journal Nature, knowing that other teams were likely to have the
same finding soon.
"In those days you couldn't just submit your paper through your computer," he
says. "You had to mail a hard copy of it to the journal. And my job was to
sprint over to the FedEx store so we could get the paper mailed on time."
Then only a few short weeks later, Landau and his colleagues made another huge
discovery, and in the process solved the final piece of the HIV puzzle. "We were
quite amazed that it all happened so quickly," Landau says.
In collaboration with a research group down the hall, Landau and his colleagues
sequenced the CCR5 gene in two people completely resistant to HIV. Lo and
behold! Both people had the same mutation in the gene — and it's a powerful
mutation. It completely cripples the molecule so that it doesn't appear on the
cells' surface, the group reported in the journal Cell. Remember, without CCR5,
HIV can't infect the cell.
"You can put as many virus particles as you want onto those cells, and they will
not get infected," he says. "So in the case of resistance to HIV, the story was
very clear."
The finding completely shifted the field of HIV. It led to the first — and only
— way to cure a person of HIV and suggested a new route, using gene editing with
CRISPR. But it did something else: It showed scientists that one mutation could
make a person completely resistant to an infection. One mutation in their genes
could make them a true superdodger.
"So when SARS-CoV-2 came along, of course, many labs looked to see if the same
might be true for this virus," Landau says. And inspired by the story of CCR5,
they went looking for mutations in the genes required for SARS-CoV-2 to enter
and infect cells.
Are there really COVID superdodgers?
For COVID superdodgers, the situation appears to be more complex than for people
resistant to HIV, Landau says, because the way SARS-CoV-2 infects cells is
different from that of HIV.
Instead of using CCR5 to "open the cell's door," SARS-CoV-2 uses the ACE2
receptor. People can't live without ACE2. "The receptor regulates your blood
pressure," Landau explains. So, unlike CCR5, you can't simply knock out the ACE2
receptor, he says. "You're not going to have many people walking around that
don't have ACE2.
"Of course, there may be more subtle mutations in ACE2 which could play a role
in resistance to SARS-CoV-2," he adds. "But there doesn't seem to be an obvious
and dramatic mutation as is the case for HIV."
But perhaps what's more likely, he says, is that people have mutations in genes
other than ACE2, and these mutations probably don't protect them from getting
infected per se but do protect them from getting sick.
So having one of these mutations would make you a sort of COVID minidodger, if
you will. There are other ways to resist an infection besides denying the virus
entrance into the cell, Landau explains. And they likely involve your body's
immune system.
That's exactly what the team at UCSF has found.
Since the pandemic began, Jill Hollenbach and her colleagues at UCSF have been
studying people who test positive COVID but show no symptoms. "Not even a
sniffle or a scratchy throat," she says. "So they are entirely asymptomatic."
After analyzing DNA from more than 1,400 people, they identified a mutation that
helps a person clear out SARS-CoV-2 so fast that their body doesn't have a
chance to develop symptoms.
The mutation occurs in a gene called HLA, which is critical during the earliest
stages of infection. Hollenbach and her colleagues found that having a
particular mutation in that gene increases a person's chance of being
asymptomatic by almost 10 times. They reported those preliminary findings online
last September.
Since then, they've gone on to show how this mutation works. And it has to do
with your immune system preparing for SARS-CoV-2 before the pandemic even began
back in 2019.
When viruses first enter cells, HLA signals to the immune system that cells are
invaded and need help. That signal triggers a cascade of events that ultimately
leads your body to make potent weapons specifically designed to fight
SARS-CoV-2. These weapons include antibodies and T cells that uniquely recognize
pieces of this virus. Once these targeted weapons are available, your immune
system has a much easier time clearing up the infection. But these weapons take
time to manufacture. And that delay allows the infection to spread and symptoms
to develop.
But what if, for some lucky reason, your immune system already had weapons
specifically targeted to SARS-CoV-2?
This summer, Hollenbach and her colleagues demonstrated that, with a specific
mutation in HLA, some people have T cells that are already pre-programmed to
recognize and fight off SARS-CoV-2. So there's no delay in generating
COVID-specfic weaponry. It's already there.
"Your immune response and these T cells fire up much more quickly [than in a
person without the HLA mutation]," Hollenbach says. "So for lack of a better
term, you basically nuke the infection before you even start to have symptoms."
But here's the kicker. For the HLA mutation to work (and for you to have these
pre-armed T cells), you first had to have been infected with another
coronavirus.
"Most of us have been exposed to some common cold coronavirus at some point in
life," she explains. And we all generate T cells to fight off these colds. But
if you also have this mutation in your HLA, Hollenbach says, then just by mere
luck, these T cells you make can also fight off SARS-CoV-2.
"It's definitely luck," she says. "But, you know, this mutation is quite common.
We estimate that maybe 1 in 10 people have it. And in people who are
asymptomatic, that rises to 1 in 5."
While Hollenbach and her team continue to look for more minidodger genes,
Casanova over at Rockefeller University and his colleagues are still trying to
determine if there are true superdodger genes. And he's looking for participants
right now for his study.
"You fill out a questionnaire online about your exposures to SARS-CoV-2," he
says. And then if you meet the criteria of a superdodger, the team sends you a
testing kit. Basically you spit in a cup and mail it back to Casanova and his
collaborators.
"We'll extract your DNA and sequence your genome," he explains. "We hope that in
a group of 2,000 to 4,000 people, some people will have genetic mutations that
tell us why they're resistant to infection."
And perhaps, like with HIV, that finding will one day shift the field of COVID
research and lead to a vaccine that does what everyone wishes our current
vaccines do: turn everyone into a COVID superdodger.
* superdodger
* COVID-19
* pandemic
* genetics
* HIV
* Facebook
* Twitter
* Flipboard
* Email
SIGN UP FOR THE GOATS AND SODA NEWSLETTER
From A to Zika, get the latest global health and development news, sent weekly.
E-mail address
subscribe
By subscribing, you agree to NPR's terms of use and privacy policy. NPR may
share your name and email address with your NPR station. See Details. This site
is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service
apply.
MORE STORIES FROM NPR
OPINION
OPINION: 'THE WOMAN KING' SPEAKS LOUD AND CLEAR TO THIS NIGERIAN FEMINIST
GLOBAL HEALTH
HIV CRASHED HER LIFE. SHE FOUND HER WAY BACK TO JOY — AND SPOKE AT THE U.N. THIS
WEEK
GLOBAL HEALTH
A BOX OF 200 MOSQUITOES DID THE VACCINATING IN THIS MALARIA TRIAL. THAT'S NOT A
JOKE!
GLOBAL HEALTH
HE WANTED HIS COMPANY TO BE THE ETSY OF AFGHANISTAN. NOW IT HAS A CRUCIAL NEW
MISSION
GLOBAL HEALTH
THE CLOCK IS TICKING FOR U.N. GOALS TO END POVERTY — AND IT DOESN'T LOOK
PROMISING
ASIA
INDIA REACTS TO QUEEN ELIZABETH II'S DEATH WITH GRIEF, ANGER — BUT MAINLY
INDIFFERENCE
POPULAR ON NPR.ORG
SCIENCE
A SECOND ANCIENT CANOE IS FOUND IN WISCONSIN — THIS TIME TRACING BACK TO 1000
B.C.
WORLD
RUSSIANS ARE PROTESTING AND FLEEING THE COUNTRY AS PUTIN ORDERS A DRAFT FOR
UKRAINE
WEATHER
TROPICAL STORM IAN THREATENS THE CARIBBEAN AND FLORIDA WITH HURRICANE CONDITIONS
FAMILY
DEAR LIFE KIT: MY PARENTS RAN A BACKGROUND CHECK ON MY PARTNER. HOW CAN I TRUST
THEM?
LAW
THE WOMAN WHO CALLED 911 ON A BLACK BIRD WATCHER WASN'T WRONGFULLY FIRED, JUDGE
RULES
WORLD
GIORGIA MELONI MAY BECOME ITALY'S 1ST FAR-RIGHT LEADER SINCE WORLD WAR II
NPR EDITORS' PICKS
POLITICS
TRUMP AND HIS LAWYERS KEEP GHOSTS OF NIXON AND WATERGATE ALIVE AND HAUNTING
SPORTS
SCANDALS? WHAT SCANDALS? HERE'S WHY FANS ARE STILL WATCHING THE NFL
FOOD
THE JEWISH FRUITCAKE: HONEY CAKE IS A SWEET AND STODGY TRADITION
FOOD
FORAGING HELPED ME DISCOVER A WORLD OF FREE FRUITS AND VEGGIES
FOOD
GET A PEEK INSIDE THIS SAUDI ARABIAN DATE FESTIVAL
NATIONAL
THE CHEROKEE NATION IS RENEWING ITS PUSH FOR A NONVOTING DELEGATE IN CONGRESS
GOATS AND SODA
STORIES OF LIFE IN A CHANGING WORLD
READ & LISTEN
* Home
* News
* Culture
* Music
* Podcasts & Shows
CONNECT
* Newsletters
* Facebook
* Twitter
* Instagram
* Press
* Contact & Help
ABOUT NPR
* Overview
* Diversity
* Ethics
* Finances
* Public Editor
* Corrections
GET INVOLVED
* Support Public Radio
* Sponsor NPR
* NPR Careers
* NPR Shop
* NPR Events
* NPR Extra
* Terms of Use
* Privacy
* Your Privacy Choices
* Text Only
* © 2022 npr
Sponsor Message
Become an NPR sponsor
By clicking “Accept All Cookies” or continuing, you agree to the use of cookies,
similar tracking and storage technologies, and information about your device to
enhance your viewing, listening and user experience, personalize content,
personalize messages from NPR’s sponsors, provide social media features, and
analyze NPR’s traffic. This information is shared with social media,
sponsorship, analytics, and other vendors or service providers. You may
customize which cookies you accept in "Cookie Settings."
Cookies Settings Accept All Cookies
PRIVACY PREFERENCE CENTER
NPR and our service providers and vendors use cookies and similar technologies
to collect information. A cookie is a string of characters that can be written
to a file on the user's computer or device when the user visits a site,
application, platform or service. When you visit a website or use a mobile
application, a computer asks your computer or mobile device for permission to
store this file on your computer or mobile device and access information from
it. Information gathered through cookies may include the date and time of visits
and how you are using the website. Note that if you disable or delete cookies,
you may lose access to certain features of the NPR Services.
User ID: 4987fcc3-8fe6-48dd-9365-69f8f703c2a6
This User ID will be used as a unique identifier while storing and accessing
your preferences for future.
Timestamp: --
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY OR ESSENTIAL COOKIES
Always Active
These cookies are essential to provide you with services available through the
NPR Services and to enable you to use some of their features. These cookies are
necessary for the website to function and cannot be switched off in our systems.
They are usually set in response to actions made by you that amount to a request
for services, such as setting your privacy preferences, logging in, or filling
in forms. You can set your browser to block or alert you about these cookies,
but some parts of the site will not then work. Without these cookies, the
services that you have asked for cannot be provided, and we only use these
cookies to provide you with those services.
PERFORMANCE AND ANALYTICS COOKIES
Performance and Analytics Cookies
These cookies are used to collect information about traffic to our Services and
how users interact with the NPR Services. The information collected includes the
number of visitors to the NPR Services, the websites that referred visitors to
the NPR Services, the pages that they visited on the NPR Services, what time of
day they visited the NPR Services, whether they have visited the NPR Services
before, and other similar information. We use this information to help operate
the NPR Services more efficiently, to gather broad demographic information and
to monitor the level of activity on the NPR Services. NPR's third-party service
providers that measure and analyze the use of the NPR Services for NPR also use
their own cookies. NPR's third-party analytics service providers use cookies
across multiple sites to collect visitor data (such as data related to age,
gender and visitor interests).
FUNCTIONAL COOKIES
Functional Cookies
These cookies allow NPR Services to remember choices you make when you use them,
such as remembering your Member station preferences and remembering your account
details. The purpose of these cookies is to provide you with a more personal
experience and to avoid you having to re-enter your preferences every time you
visit the NPR Services. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
TARGETING AND SPONSOR COOKIES
Targeting and Sponsor Cookies
These cookies track your browsing habits or other information, such as location,
to enable us to show sponsorship credits which are more likely to be of interest
to you. These cookies use information about your browsing history to group you
with other users who have similar interests. Based on that information, and with
our permission, we and our sponsors can place cookies to enable us or our
sponsors to show sponsorship credits and other messages that we think will be
relevant to your interests while you are using third-party services. NPR works
with third-party vendors that may serve sponsorship credits or other messages to
you on other websites after you visit the NPR Services. These third-party
vendors use their own cookies to recognize you as an NPR Services visitor and to
serve you sponsorship credits or other messages on other websites that they
believe you will find most relevant. If you do not allow these cookies, you may
still receive sponsorship or marketing messages, but they may not be targeted to
your interests.
Back Button
PERFORMANCE COOKIES
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Reject All Confirm My Choices